Effectiveness and economic evaluation of chiropractic care for the treatment of low back pain: a systematic review protocol by Marc-André Blanchette et al.
Blanchette et al. Systematic Reviews  (2015) 4:30 
DOI 10.1186/s13643-015-0015-5PROTOCOL Open AccessEffectiveness and economic evaluation of
chiropractic care for the treatment of low back
pain: a systematic review protocol
Marc-André Blanchette1*, André Bussières2,3,4, Mette Jensen Stochkendahl5, Jill Boruff6 and Pamela Harrison6Abstract
Background: Chiropractic care is a common treatment for low back pain (LBP). Previous studies have failed to
clarify the relative cost-effectiveness of chiropractic care in comparison with other commonly used approaches
because previous attempts to synthetize the economic literature has only included partial economic evaluations.
The objective of this project is to estimate the clinical effectiveness and cost-effectiveness of chiropractic care compared
to other commonly used care approaches among adult patients with non-specific LBP.
Methods/design: Two systematic reviews will be conducted to identify 1) randomized controlled trials and 2) full
economic evaluations of chiropractic care for low back pain compared to standard care provided by other healthcare
providers. We will conduct searches in specialized electronic databases for randomized controlled trials and full economic
evaluations published between 1990 and 2014 using a combination of keywords and MeSH terms. This will be
supplemented by a search of the gray literature. Citations, abstracts, and relevant papers will be screened for
eligibility by two reviewers independently. Studies will be critically appraised using 1) the Cochrane risk of bias
tool and 2) the Drummond (BMJ) checklist. Results will be summarized using Slavin’s qualitative best-evidence
synthesis approach. Data relating to the primary outcomes of the effectiveness study will be evaluated for inclusion in
meta-analyses. The costs will be standardized to the same currency (USD) and adjusted to the same year for inflation.
The incremental cost-effectiveness, incremental net benefit, and relevant confidant intervals will be recalculated in order
to facilitate comparison between studies.
Discussion: Our review will evaluate both the clinical effectiveness and the cost-effectiveness associated with
chiropractic care for LBP. A more precise estimate of the cost-effectiveness of chiropractic care for LBP relative to
other forms of conservative care is needed for decision-makers and third-party payers to offer best care options for LBP.
Our results will facilitate evidence-based management of patients with LBP and identify key areas for future research.
Systematic review registration: The protocol is registered on PROSPERO (CRD42014008746).
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Low back pain (LBP) remains a leading cause of disabil-
ity worldwide, accounting for over 10% of the total of
‘years lived with disability’ [1]. LBP is the most common
occupational injury in Canada and United States [2,3]. It
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unless otherwise stated.among health problems in terms of direct medical costs
in North America [4].
The incidence of non-specific LBP has not significantly
increased in the last four decades [5-7]. However, a dras-
tic increase in the number of certificates of illness and
benefits paid for chronic disabilities resulting from LBP
has been reported in industrialized countries since the
1980s [8]. Such increase in disability level has had an
alarming impact on costs due to lost productivity, wage
replacement, and health care utilization. According to
the 2010 Global Burden of Disease Study, low back paintral. This is an Open Access article distributed under the terms of the Creative
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in 1990 to 83.0 million in 2010 [9]. With the hope of re-
ducing the significant health and economic burden asso-
ciated with LBP, researchers have examined the
effectiveness of numerous treatment options, including
manual therapy [10-14].
Opinions vary widely on what causes LBP and how
best to manage it [15]. It is estimated that over 85% of
patients with LBP have symptoms that are ‘non-specific’
in nature since they cannot reliably be attributed to a
specific disease or anatomical structure [16]. Perhaps as
a result, relatively few treatment modalities for the man-
agement of LBP have been shown to achieve superior
and sustained improvements in pain, physical function,
and disability [17,18]. An example is spinal manipulative
therapy (SMT), which recent reviews did not find signifi-
cantly more effective than and other modalities
[11,19,20]. SMT is often a core component of chiroprac-
tic care [21], but chiropractic care is not restricted to the
use of SMT [22], and a range of other treatment modal-
ities may be offered exclusively or in combination with
SMT to potentially compliment or enhance treatment
outcome. Moreover, SMT is not performed exclusively
by chiropractors but is used extensively worldwide by a
range of other health care professionals [11,20]. In the
case of SMT, studies on the effectiveness may guide cli-
nicians (chiropractors and others) in their choice of
treatment modality, but offer little information to pa-
tients, policy makers, and third-party payers about the
clinical effectiveness and cost-effectiveness of standard
care offered by different providers.
Considering this, older reports [23,24] have pointed
to chiropractic care as efficient for the treatment of
LBP because of the relatively low fee for service, the
use of ‘low tech’ therapies such as manual therapy, and
the low usage of costly investigations such as advanced
diagnostic imaging. However, when compared with
medical and physiotherapy care, economic reviews have
not been able to support this or provide clear guidance
to informed decision-making regarding the many avail-
able provider options [25,26]. This divergence in find-
ings may be partly due to the limited number of studies
of acceptable methodological quality [25,27] and partly
because the previous systematic reviews have only in-
cluded partial economic evaluation (cost description,
cost analysis, and cost-outcome description). The last
systematic review of economic and clinical effectiveness
studies of chiropractic care was completed nearly a
decade ago and provided limited guidance [25]. We are
conducting this review with the hope of including more
high quality studies.
When evaluating standard care for LBP, decisions to
recommend any one option should preferably be based
on the clinical effectiveness, the cost-effectiveness, thesafety of the approach, and patient preference [11,19,26].
Only full economic evaluation (cost-effectiveness ana-
lysis, cost-utility analysis, cost-benefit analysis) of stand-
ard care practice can provide adequate information
about resource inputs (costs) and outputs (health out-
comes) [28] and evaluate whether healthcare resources
are being used optimally [29]. In order to better inform
patients, policy makers, and third-party payers about the
clinical effectiveness and cost-effectiveness of standard
chiropractic care for LBP in comparison to usual stand-
ard care provided by other health care professionals, an
evidence synthesis is indicated.
Objectives
The two main objectives of this review are 1) to estimate
the extent to which chiropractic care is effective for
adult patients with non-specific low back pain compared
to other conservative care approaches (for example,
medical care and physiotherapy) and 2) to estimate the
cost-effectiveness of chiropractic care for adult patients




To be eligible for inclusion, studies must meet the fol-
lowing criteria:
1. The study design is:
– a randomized controlled trial for the clinical
effectiveness studies;
– a full economic evaluation (including cost-
effectiveness, cost-utility, cost-benefit analyses,
and cost-minimization analysis alongside a clinical
trial [30]) for the economic studies.
2. The population under study is composed of adult
patients (≥18 years) with non-specific LBP with or
without sciatica of any duration. Studies reporting
multiple pain locations or spinal pain without separate
results for LBP will be excluded.
3. The intervention is chiropractic care. Studies that
evaluate chiropractic care as part of a combined,
multidisciplinary approach will be excluded unless
the chiropractic care part is evaluated separately.
Studies that evaluate specific treatment modalities
(for example, SMT) will be excluded.
4. The comparator is non-surgical, usual conservative
care delivered by other healthcare providers (for
example, medical therapy, physical therapy, or
acupuncture). Studies including surgical treatment
of LBP as the only comparator will be excluded.
5. The outcome must include - for the clinical
effectiveness studies - one or more of the following
primary or secondary effect measures:
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 Pain (for example, visual analog scale, numerical
rating scale, McGill pain score)
 Functional status (for example, Roland-Morris
questionnaire, Oswestry Disability Index)
 Global improvement (for example, the number of
patients reporting to have recovered)
Secondary outcomes
 Health related quality of life (for example, SF-36,
EuroQol)
 Return to work
 Adverse effects
–For the economic studies: an incremental measure of
the extra budget required to improve an additional unit
of outcome (that is, an incremental cost-effectiveness
ratio or an incremental net benefit measure) with the ex-
ception of cost-minimization studies.
6. Studies must be published in English or French.
7. Studies without full-text manuscript available (for
example, abstracts, conference proceedings,
presentations) and duplicate study reports will be
excluded. Published study protocol will be registered
but not included in the data analysis.
Information sources and search
A comprehensive literature search will be conducted
using indexed subject headings and free text related to
the topic of interest in electronic health literature data-
bases, as well as gray literature sources (economic evalu-
ations only), to uncover potentially relevant studies.
With the exception of PubMed, the search will be lim-
ited to studies published between 1990 and the search
date. Since the volume of literature on back pain is
impressive, we restricted search to 1990 (start date) as it
corresponds with the first potentially relevant studies in
this topic. This start date will enable us to select rela-
tively recent literature that is compatible with the con-
temporary practice of both chiropractic and comparator
providers. The PubMed search will be used to retrieve
the most recent publications and restricted to items
published on or after 2014.
Searches will be conducted in the following electronic
databases: Ovid Medline, Ovid AMED, Ovid EMBASE,
CINAHL, the Cochrane Database of Systematic Reviews,
and PubMed. In addition, we will also search for economic
evaluations in the following: Index to Chiropractic Litera-
ture (ICL), Cochrane Library, Health Technology Assess-
ment Database, and ECONLIT. Finally, a search of the
gray literature for economic evaluations will include thewebsites of the following organization: Canadian Institute
for Health Information (CIHI), Canadian Agency for
Drugs and Technologies in Health (CADTH), Canadian
Institute of Health Research (CIHR), Tufts Medical Center
Cost-effectiveness Analysis Registry, Agency for Health-
care Research and Quality, National Institute for Health
Research Health Technology Assessment program, and
National Institute for Health and Care Excellence (NICE).
The search strategy will be different for each database,
and the RCT filters for PubMed, Ovid Medline, AMED,
EMBASE, and CINAHL will be adapted from the
Cochrane Highly Sensitive Search Strategy for identify-
ing randomized trials in MEDLINE [31]. The search in
Cochrane will be limited to Cochrane Central (Trials) to
exclude other study designs. Two clinical librarians (JB
and PH), with experience in searching for systematic re-
views, developed a search strategy for each individual
database and will conduct the searches. The search strat-
egy for clinical effectiveness and for cost-effectiveness
can be found in Appendix 1 and 2, respectively. We will
screen the bibliographies of relevant publications,
including reviews and meta-analyses, for additional rele-
vant articles.
Study selection
Titles and abstracts of studies identified from the litera-
ture search will be combined using Endnote 14 and
screened for relevance by two independent reviewers to
identify all articles that any reviewer judges potentially
eligible. The same reviewers will independently apply
eligibility criteria to the full-text manuscript of all poten-
tially eligible studies. Disagreements will be discussed
until consensus. Disagreements will be resolved with ar-
bitration by a third reviewer if disagreements persist.
Quality assessment and analysis
All eligible studies on clinical effectiveness will be
assessed for methodological quality (risk of bias) by two
independent reviewers. Studies assessing clinical effect-
iveness will be evaluated using 12 criteria recommended
by the Cochrane Back Review Group [32]. These criteria
include blinding of the patient, treatment provider, and
outcomes assessor. Studies that meet at least 6 criteria
out of 12 will be considered at low risk of bias, while the
others will be considered at high risk of bias.
Studies assessing costs will be evaluated using a rec-
ommended tool for health economic evaluations, the
Drummond (BMJ) checklist [29,33,34]. This checklist
includes 35 items grouped into four broad categories:
general issues about study design, data collection, data
analysis, and interpretation of results. Any disagree-
ments between reviewers will be discussed until consen-
sus is reached or with arbitration by a third reviewer if
disagreements persist. The quality level (low, medium,
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between three investigators (AB, MAB, MJS). This will
enable the investigators to formulate a qualitative appre-
ciation of the complete study.
Data extraction
Data will be extracted separately by two independent
reviewers; any disagreements will be resolved through
discussion, with arbitration by a third reviewer if neces-
sary. Authors of potentially relevant studies will be con-
tacted regarding additional information or missing data.
Key findings from each study will be summarized and
presented in a summary tables. Two separate forms will
be used for clinical effectiveness studies and economic
evaluations. For clinical effectiveness studies, we will use
the Cochrane back review group data extraction form
[35]. Extracted variables will include author and year;
country; participants, indication, setting; compared treat-
ments; time horizon, outcomes assessed; authors’ results;
and conclusion.
Data from economic evaluations will be extracted using
a customized data extraction sheet (Additional file 1).
Extracted variables will include author and year; country;
type of economic evaluation; participants, indication,
setting; compared treatments; perspective; time horizon,
currency price (year); included costs, health effect (pain,
functional status, global improvement, health-related qual-
ity of life, return to work); mean costs, mean quality-
adjusted life years (QALYs); incremental cost-effectiveness
statistics; limitations; and authors’ conclusion.
Measures of effect estimates
Continuous outcomes measured with the same instru-
ment (that is, pain measured with visual analog scale)
will be compared using mean difference, whereas con-
tinuous outcomes measured with different instruments
(that is, functional status measured with Roland-Morris
or Oswestry tools) will be compared using standardized
mean difference. For dichotomous outcomes (that is, re-
covery, return-to-work), a risk ratio will be generated.
Data analysis
Effect measures relating to the primary and secondary
outcomes of clinical effectiveness studies with low risk
of bias, and no serious flaw will be evaluated for inclu-
sion in the meta-analyses. Outcomes will be assessed at
1, 3, and 12 months and will be categorized according to
the time closest to these intervals. In order to minimize
clinical diversity, we will stratify by healthcare provider
(for example, chiropractic care versus medical care or
chiropractic care versus physiotherapy), symptom dur-
ation (acute (0 to 6 weeks), sub-acute (6 to 12 weeks),
chronic (more than 12 weeks), and mixed/not specified),
and outcomes (type of outcome and time of assessment).Heterogeneity will be investigated by subjective inter-
pretation and by statistical testing using the Q and I2
test. A cutoff of 40% at the I2 test will determine the
limit of acceptable heterogeneity. If the I2 cutoff is
exceeded or the description of the average care provided
by the comparator seems too heterogeneous, results will
be discussed narratively in the manuscript without
pooled estimates. A sensitivity analysis will be performed
by including studies with high risk of bias. Funnel plots
will be constructed using all data from the primary out-
comes regardless of the comparator or follow-up interval
in order to evaluate possible publication bias.
For the economic evaluations, the difference in per-
spective of analysis, type of economic analysis, and
healthcare system will be discussed narratively. To allow
direct comparisons across countries and years, we will
convert reported costs estimates to 2014 United States
(US) dollars. International exchange rate based on pur-
chasing power parities (PPP) will be use to convert cost
estimates to US dollars, and gross domestic product
(GDP) deflators will be use to convert cost estimates to
2014. PPP and GDP are available from the World
Economic Outlook Database (http://www.imf.org/external/
data.htm). Results comparing chiropractic to other
types of care will be summarized using Slavin’s [36]
qualitative best-evidence synthesis approach, which as-
sumes that the strength of a relationship between vari-
ables is based on the quantity and quality of the
evidence available. This approach aims to provide meth-
odological rigor by clearly and concisely articulating the
synthesis criteria and was recently used in a number of
systematic reviews related to occupational health [37-39].
The level of evidence uncovered for the findings of inter-
est will be assessed using a 5-point ordinal scale (strong,
moderate, limited, mixed, and insufficient evidences) de-
fined by Slavin [36]. The appropriate level of evidence for
each finding will be assessed in a stepwise manner by first
determining if criteria for the highest level of evidence
(that is, strong) are fulfilled and, if they are, no further
evaluation is performed. If those criteria are not fulfilled,
those for the next lowest level of evidence are then
assessed, continuing until the appropriate level of evidence
can be assigned to the various review findings. The criteria
for each level of evidence are the following:
Strong evidence
Minimum of three high quality studies; at least three
quarters of high and medium quality studies must con-
cur on findings.
Moderate evidence
Minimum of two high quality studies or three of
medium and high quality; more than two thirds of all
studies must report consistent findings.
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Minimum of one high quality study or two medium
quality studies, more than 50% of all studies must report
consistent findings.
Mixed evidence
Findings from medium and high quality studies are
contradictory.
Insufficient/no evidence
No high quality studies; one or no medium quality stud-
ies; any number of low quality studies.
Protocol registration
Our protocol is registered on PROSPERO (CRD4201
4008746), http://www.crd.york.ac.uk/PROSPERO. This
manuscript conforms to the PRISMA guidelines [40]
that are relevant to the reporting of a systematic review
protocol. We present our methods and analysis for the
review of clinical effectiveness and our review of eco-
nomic evaluations separately.
Discussion
Our research team includes French and English investi-
gators. The potential of omitting important studies in
other languages is considered very small since chiroprac-
tic is of English/American origin and is primarily prac-
ticed in the anglophone countries.
Decisions regarding optimal care should be based on
aspects of importance to all stakeholders, including clin-
ical effectiveness, harms, patient preference, and cost-
effectiveness. A more precise estimate of the cost-
effectiveness of chiropractic care for LBP relative to
other forms of conservative care is needed for decision-
makers and third-party payers to offer best care options
for LBP. Evidence is also needed to help guide employer
and regulatory decisions to reduce unnecessary costs for
work-related LBP resulting in temporary or permanent
disability [18].
Appendix 1: Search strategy for the review of
clinical effectiveness
PUBMED








(“back disorder”[tiab] OR “back disorders”[tiab]) OR
(sciatic[tiab] OR sciatica[tiab]) OR
ischialgia[tiab] OR((degenerate[tiab] OR degeneration[tiab] OR degen-
erating[tiab] OR degenerated[tiab] OR prolapse[tiab]
OR prolapsing[tiab] OR prolapsed[tiab] OR hernia
[tiab] OR hernias[tiab] OR herniating[tiab] OR herni-
ate[tiab] OR herniated[tiab] OR bulge[tiab] OR bulges
[tiab] OR bulging[tiab] OR bulged[tiab] OR protrude
[tiab] OR protruding[tiab] OR protruded[tiab] OR
protrusion[tiab] OR protrusions[tiab] OR extrude[tiab]
OR extruding[tiab] OR extruded[tiab] OR extrusion
[tiab] OR extrusions[tiab] OR sequestrate[tiab] OR se-
questrated[tiab] OR sequestrating[tiab] OR sequestra-
tion[tiab] OR sequestrations[tiab] OR disorder[tiab]
OR disorders[tiab] OR disordered[tiab] OR disease
[tiab] OR diseases[tiab] OR diseased[tiab] OR rupture
[tiab] OR ruptures[tiab] OR ruptured[tiab] OR slip
[tiab] OR slips[tiab] OR slipped[tiab]) AND (disc[tiab]
OR discs[tiab] OR discal[tiab] OR disk[tiab] OR disks
[tiab])) OR
(“spinal stenosis"[tiab] OR “spinal stenoses”[tiab]) OR
(“lumbar stenosis”[tiab] OR “lumbar stenoses”[tiab)]
OR
(discitis[tiab] OR discitides[tiab] or diskitis[tiab] OR
diskitides[tiab] OR spondylodiskitis[tiab] OR spondylo-
diskitides[tiab] OR spondylodiscitis[tiab] OR spondylo-
discitides[tiab]) OR
(“vertebrogenic pain syndrome”[tiab] OR “vertebro-
genic pain syndromes”[tiab]) OR








(spinal[tiab] OR lumbar[tiab] OR cervical[tiab]) AND
manipulation[tiab]) OR
(chiropractic[tiab] OR chiropraxic[tiab]) OR
((back[tiab] OR spine[tiab] OR spinal[tiab] OR lumbar
[tiab] OR musculoskeletal[tiab]) AND (adjustment[tiab]
OR adjustments[tiab] OR adjusting[tiab] OR adjust[tiab]
OR adjusted[tiab] OR manipulation[tiab] OR manipula-
tions[tiab] OR manipulating[tiab] OR manipulate[tiab]
OR manipulated[tiab] or mobilization[tiab] or mobilisa-
tion[tiab])) OR
(“musculoskeletal manipulation”[tiab] OR “musculo-
skeletal manipulations”[tiab] OR “manual therapy”[tiab]
OR “manual therapies”[tiab] OR “manipulation thera-
py”[tiab] OR “manipulation therapies”[tiab] “manipula-
tive therapy”[tiab] OR “manipulative therapies”[tiab])
OR
(manipulation[tiab] AND medicine[tiab]) OR (manipu-
lations[tiab] AND medicine[tiab]) OR
flexion[tiab] OR
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ses”[tiab] OR “myofascial therapy”[tiab] OR “myofas-
cial therapies”[tiab]) OR
(“muscle energy technique”[tiab] OR “muscle energy
techniques”[tiab]) OR
(“trigger point”[tiab] OR “trigger points”[tiab] OR
“trigger area”[tiab] OR “trigger areas”[tiab]) OR
"Proprioceptive Neuromuscular Facilitation"[tiab] OR
"Cyriax Friction"[tiab] OR
"strain counterstrain"[tiab] OR
(craniosacral[tiab] OR "cranio sacral"[tiab]) OR
("complementary therapy”[tiab] OR “complementary
therapies”[tiab] OR “alternative therapy”[tiab] OR “alter-














Database: Ovid MEDLINE(R) In-Process & Other
Non-Indexed Citations, Ovid MEDLINE(R) Daily,
Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) 1946
to Present





6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
8. (Sciatic adj3 (Neuralgia or Bilateral)).ti,ab.
9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.Spinal Stenosis/






17.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.18.(lumbar adj3 (ache* or pain* or strain*)).tw.
19.lumbar vertebrae.mp.
20.(lumbago or dorsalgia).tw.
21.1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11






26.((back or spine or spinal or lumbar or




29.(Manipulati* adj (therap* or medicine)).tw.
30.(Flexion adj2 distraction*).tw.





















51.49 not (49 and 50)
52.48 not 51
53.21 and 40 and 52
54.limit53 to yr=”1990-Current”
AMED







6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
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9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.Spinal Stenosis/





16.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.








25.((back or spine or spinal or lumbar or




28.(Manipulati* adj (therap* or medicine)).tw.
29.(Flexion adj2 distraction*).tw.





















51.49 not (49 and 50)
52.48 not 51
53.20 and 39 and 52
54.limit 53 to yr=”1990-Current”EMBASE







6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
8. (Sciatic adj3 (Neuralgia or Bilateral)).tw.
9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.vertebral canal Stenosis/






17.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.






24.((back or spine or spinal or lumbar or




27.(Manipulati* adj (therap* or medicine)).tw.
28.(Flexion adj2 distraction*).tw.



















48.46 not (46 and 47)
49.45 not 48
50.21 and 37 and 49
51.limit 50 to yr=”1990-Current”
CINAHL
Database: CINAHL Plus with Full Text (Full text
from 1937-)
S44. S13 AND S25 AND S43; Limiters: Published
Date: 19900101-
S43. 39 NOT S42
S42. S40 NOT (S40 AND S41)
S41. (MH “Human”)
S40. (MH “Animals”)
S39. S26 OR S27 or S28 or S29 or S30 or S31 or S32













S26. (PT clinical trial) OR (PT randomized controlled
trial)
S25. S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR
S20 OR S21 OR S22 OR S23 OR S24
S24. (MH “Trigger Point”)
S23. (MH “Manual Therapy”)
S22. TI ( (Strain N1 counterstrain) or “Craniosacral
Therap*” or “Cranio sacral Therap*” ) OR AB ( (Strain
N1 counterstrain) or “Craniosacral Therap*” or “Cranio
sacral Therap*” )
S21. TI ( “muscle energy technique*” or “trigger
point*” or “Proprioceptive Neuromuscular Facilita-
tion” ) OR AB ( “muscle energy technique*” or
“trigger point*” or “Proprioceptive Neuromuscular Fa-
cilitation” )
S20. TI ( (myofascial) N3 (release or therap*) ) OR AB
( (myofascial) N3 (release or therap*) )
S19. TI (Flexion N2 distraction*) OR AB (Flexion N2
distraction*)
S18. TI ( (Manipulati* N1 (therap* or medicine)) ) OR
AB ( (Manipulati* N1 (therap* or medicine)) )
S17. TI “manual therap*” OR AB “manual therap*”S16. TI ( ((back or spine or spinal or lumbar or mus-
culoskeletal) N3 (adjust* or manipulat* or mobili*ation))
) OR AB ( ((back or spine or spinal or lumbar or muscu-
loskeletal) N3 (adjust* or manipulat* or mobili*ation)) )
S15. TI chiropract* OR AB chiropract*
S14. (MH “Chiropractic + ”)
S13. S1 OR S2 OR S3 OR S12
S12. S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10
OR S11
S11. TI ( “lumbar vertebrae” or lumbago or dorsalgia )
AND AB ( “lumbar vertebrae” or lumbago or dorsalgia)
S10. TI ( ((lumbar) N3 (ache* or pain* or strain*)) )
AND AB ( ((lumbar) N3 (ache* or pain* or strain*)) )
S9. TI ( ((Zygapophyseal or Facet or facets) N3 (syn-
drome* or degenerat*)) ) OR AB ( ((Zygapophyseal or
Facet or facets) N3 (syndrome* or degenerat*)) )
S8. TI ( spondylodiscitis OR “vertebrogenic pain syn-
drome* ) OR AB ( spondylodiscitis OR ”vertebrogenic
pain syndrome* )
S7. TI ( ((stenosis or stenoses) N3 (lumbar or spine or
spines or spinal)) ) OR AB ( ((stenosis or stenoses) N3
(lumbar or spine or spines or spinal)) )
S6. TI ( ((disc* or disk*) N3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or extrusion*
or sequestration* or disorder* or disease* or rupture* or
slipped)) ) OR AB ( ((disc* or disk*) N3 (degener* or dis-
place* or prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease* or
rupture* or slipped)) )
S5. TI ( (sciatic N3 (neuralgia or bilateral)) ) OR AB (
(sciatic N3 (neuralgia or bilateral)) )
S4. TI ( “back pain” or backache* or sciatica or “spine
pain” or “spinal pain” or “back disorder*” ) OR AB (
“back pain” or backache* or sciatica or “spine pain” or
“spinal pain” or “back disorder*” )
S3. (MH “Spinal Stenosis”)
S2. (MH “Sciatica”)
S1. (MH “Back Pain + ”)
COCHRANE
1. MeSH descriptor: [Back Pain] explode all trees
2. MeSH descriptor: [Sciatica] explode all trees
3. MeSH descriptor: [Spinal Stenosis] explode all trees
4. MeSH descriptor: [Discitis] explode all trees
5. back near pain:ti,ab,kw
6. backache* or sciatica or spine near pain or spinal
near pain or back near disorder*:ti,ab,kw
7. (sciatic near/3 (neuralgia or bilateral)) or ((disc* or
disk*) near/3 (degener* or displace* or prolaps* or
hernia* or bulge or protrusion* or extrusion* or
sequestration* or disorder* or disease* or rupture*
or slipped))
8. ((stenosis or stenoses) near/3 (lumbar or spine or
spines or spinal)) or spondylodiscitis or ((Zygapophyseal
Blanchette et al. Systematic Reviews  (2015) 4:30 Page 9 of 12or Facet or facets) near/3 (syndrome* or degenerat*)) or
((lumbar) near/3 (ache* or pain* or strain*)) or “lumbar
vertebrae” or lumbago or dorsalgia
9. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8
10.MeSH descriptor: [Manipulation, Spinal] explode
all trees
11.MeSH descriptor: [Manipulation, Chiropractic]
explode all trees
12.MeSH descriptor: [Chiropractic] explode all trees
13.MeSH descriptor: [Musculoskeletal Manipulations]
this term only
14.MeSH descriptor: [Trigger Points] explode all trees
15.MeSH descriptor: [Complementary Therapies] this
term only
16.chiropract* or ((back or spine or spinal or lumbar
or musculoskeletal) near/3 (adjust* or manipulat*
or mobili*ation)) or manual near therap* or
(Manipulati* near (therap* or medicine)) or
(Flexion near/2 distraction*) or (myofascial near/3
(release or therap*)) or trigger near point* or
(Strain near counterstrain) or Craniosacral near
Therap*:ti,ab,kw
17.#10 or #11 or #12 or #13 or #14 or #15 or #16
18.#9 and #17
Note: Only include results from Cochrane Central
(Trials); publication date 1990-
Appendix 2: Search strategy for the review of
economic evaluation
MEDLINE





6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
8. (Sciatic adj3 (Neuralgia or Bilateral)).ti,ab.
9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.Spinal Stenosis/






17.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.
18.(lumbar adj3 (ache* or pain* or strain*)).tw.19.lumbar vertebrae.mp.
20.(lumbago or dorsalgia).tw.
21.1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11






26.((back or spine or spinal or lumbar or




29.(Manipulati* adj (therap* or medicine)).tw.
30.(Flexion adj2 distraction*).tw.











42.exp “Costs and Cost Analysis”/
43.“Value of Life”/
44.resource allocation/ or exp economics, medical/ or
“fees and charges”/
45.(econom* or cost* or pric* or fee or fees or
expense* or saving* or financial or “loss reduction”
or payback* or “return on investment”).tw.












6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
8. (Sciatic adj3 (Neuralgia or Bilateral)).ti,ab.
9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
Blanchette et al. Systematic Reviews  (2015) 4:30 Page 10 of 12extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.vertebral canal Stenosis/






17.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.
18.(lumbar adj3 (ache* or pain* or strain*)).tw.
19.lumbar vertebrae.mp.
20.(lumbago or dorsalgia).tw.
21.1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11




24.((back or spine or spinal or lumbar or




27.(Manipulati* adj (therap* or medicine)).tw.
28.(Flexion adj2 distraction*).tw.







36.(Craniosacral Therap* or Cranio sacral Therap*).tw.
37.economics/
38.exp economic evaluation/
39.resource allocation/ or health economics/ or
medical fee/
40.(econom* or cost* or pric* or fee or fees or
expense* or saving* or financial or “loss reduction”
or payback* or “return on investment”).tw.











6. (spine pain or spinal pain).tw.
7. back disorder*.tw.
8. (Sciatic adj3 (Neuralgia or Bilateral)).ti,ab.
9. ischialgia.tw.
10.((disc* or disk*) adj3 (degener* or displace* or
prolaps* or hernia* or bulge or protrusion* or
extrusion* or sequestration* or disorder* or disease*
or rupture* or slipped)).tw.
11.Spinal Stenosis/





16.((Zygapophyseal or Facet or facets) adj3 (syndrome*
or degenerat*)).tw.







24.((back or spine or spinal or lumbar or




27.(Manipulati* adj (therap* or medicine)).tw.
28.(Flexion adj2 distraction*).tw.












40.exp “Costs and Cost Analysis”/
41.“fees and charges”/
42.(econom* or cost* or pric* or fee or fees or
expense* or saving* or financial or “loss reduction”
or payback* or “return on investment”).tw.





48.38 and 46 and 47
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Almost identical to MEDLINE
Additional file
Additional file 1: Data extraction form for economic evaluation.
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